Risk of tuberculosis in patients treated with anti‐tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden

Publisher： John Wiley & Sons Inc

E-ISSN： 1756-185x|18|3|323-330

ISSN： 1756-1841

Source： INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol.18, Iss.3, 2015-03, pp. : 323-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The risk of tuberculosis in patients with psoriasis treated with anti‐tumor necrosis factor agents

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 5, 2015-05 ,pp. : 594-599

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-α Treatment

By  

Respiration, Vol. 90, Iss. 3, 2015-0 ,pp. : 191-198

Karger

Access to resources Recommend Favorite

Tuberculosis screening prior to anti‐tumor necrosis factor therapy among patients with immune‐mediated inflammatory diseases in Japan: a longitudinal study using a large‐scale health insurance claims database

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 20, Iss. 11, 2017-11 ,pp. : 1674-1683

John Wiley & Sons Inc

Access to resources Recommend Favorite

Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti‐tumor necrosis factor treatment. Part 1: Risk assessment

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 1, 2018-01 ,pp. : 20-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of liver cirrhosis in patients with tuberculosis: a nationwide cohort study

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 7, 2015-07 ,pp. : 663-669

John Wiley & Sons Inc

Access to resources Recommend Favorite